Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Keiretsu Forum Mid-Atlantic
AddedFeb 16, 2024
UpdatedJun 28, 2026
Keiretsu Forum Mid-Atlantic

Keiretsu Forum Mid-Atlantic

Operating

Keiretsu Forum Mid-Atlantic: Your gateway to vetted international angel funding opportunities.

Location
Atlantic Mine, MI, US
Founded
2010
Firm
Compare
Portfolio
Employees
Website

Keiretsu Forum Mid-Atlantic is an angel investment network connecting investors with innovative entrepreneurs. The organization focuses on early-stage funding opportunities across various sectors, with a particular emphasis on Series A and Seed rounds. Their approach combines global opportunities with local expertise, offering vetted international investment prospects to their members.

Notable portfolio companies include Astarte Medical Partners, Soteria Battery Innovation Group, and iQure Pharma. Keiretsu Forum Mid-Atlantic provides a comprehensive deal screening and due diligence process, allowing investors access to a large group of sophisticated angel investors. The organization also offers educational resources to enhance members' investment knowledge and expertise.

Keiretsu Forum Mid-Atlantic - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments7
Current Portfolio Count7
Total Portfolio Exits0

Top Investment Stages

Series A5 (71.4%)
Seed1 (14.3%)
Series Unknown1 (14.3%)

Stage Mix

Series A 71%Seed 14%Series Unknown 14%

Concentration shown as share of disclosed investments by stage.

Recent Investments

iQure Pharma logo

iQure Pharma

Soteria Battery Innovation Group logo

Soteria Battery Innovation Group

ExpressCells logo

ExpressCells

Astarte Medical Partners logo

Astarte Medical Partners

Phytonix logo

Phytonix

Chiefofstaff.com logo

Chiefofstaff.com

Tassl logo

Tassl

Keiretsu Forum Mid-Atlantic - Similar Investment Firms

Keiretsu Forum Midwest logo

Keiretsu Forum Midwest

keiretsuforum.com

Keiretsu Forum logo

Keiretsu Forum

Keiretsu Forum Northwest logo

Keiretsu Forum Northwest

keiretsuforum.com

Keiretsu Forum CEE logo

Keiretsu Forum CEE

keiretsuforum.eu

Mid Atlantic Angel Fund logo

Mid Atlantic Angel Fund

Mid-Atlantic Angel Group logo

Mid-Atlantic Angel Group

magfund.com

Jumpstart New Jersey Angel Network logo

Jumpstart New Jersey Angel Network

jumpstartnj.org

Keiretsu Forum Turkey logo

Keiretsu Forum Turkey

Keiretsu Capital logo

Keiretsu Capital

Broad Street Angels logo

Broad Street Angels

Northeast Angels logo

Northeast Angels

North Country Angels logo

North Country Angels

Empire Angels logo

Empire Angels

empireangels.com

Executive Forum Angels logo

Executive Forum Angels

TiE Angels logo

TiE Angels

tieangels.com

Keiretsu Forum Mid-Atlantic - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end